2740-4218

Visualized Cancer Medicine

EDP Sciences

View prefix report (10.1051)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 37 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact37 DOIs
2

Add abstracts to 1 article

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact1 DOIs
3

Deposit reference lists for 1 record

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 53 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 An increase in early cancer detection rates at a single canc… (10.1051/vcm/2022001)
ORCID
30.10 15
2 Spatially-resolved proteomics and transcriptomics: An emergi… (10.1051/vcm/2020002)
ORCID
26.03 10
3 Updates on altered signaling pathways in tumor drug resistan… (10.1051/vcm/2024007)
ORCID
26.03 10
4 Comparison of cyclotron and synchrotron in particle therapy (10.1051/vcm/2024008)
ORCID
25.00 9
5 Enabling clinical use of linear energy transfer in proton th… (10.1051/vcm/2025001)
ORCID
22.58 7
6 MxA: a broadly acting effector of interferon-induced human i… (10.1051/vcm/2022002)
ORCID
21.13 6
7 Challenges and benefits of implementing DIBH for breast canc… (10.1051/vcm/2023005)
ORCID
19.45 5
8 Roles of heat shock proteins in tumor immune microenvironmen… (10.1051/vcm/2024002)
ORCID
19.45 5
9 Dosimetric comparison of intensity-modulated proton radiothe… (10.1051/vcm/2021002)
ORCID
17.47 4
10 CBP/p300 bromodomain: new promising epigenetic target (10.1051/vcm/2022004)
ORCID
17.47 4
11 Friend or Foe? The fascinating Tudor-SN protein (10.1051/vcm/2023001)
ORCID
17.47 4
12 Clinical advances in nasopharyngeal carcinoma surgery and a… (10.1051/vcm/2021001)
ORCID
15.05 3
13 Benefits of precision medicine in lung cancer: experience fr… (10.1051/vcm/2022005)
ORCID
15.05 3
14 Integrin α6 targeted cancer imaging and therapy (10.1051/vcm/2022007)
ORCID
15.05 3
15 Promoting music intervention training in oncology in China:… (10.1051/vcm/2024010)
ORCID
15.05 3
16 Targeting myofibroblastic cancer-associated fibroblasts (myC… (10.1051/vcm/2025005)
ORCID
15.05 3
17 Foreword for Visualized Cancer Medicine: The era for dynamic… (10.1051/vcm/2020001)
ORCID
11.93 2
18 Licensing instead of fueling: Glutamine synthetase promotes… (10.1051/vcm/2022009)
ORCID
11.93 2
19 Revisiting and proposing the most important questions in can… (10.1051/vcm/2024003)
ORCID
11.93 2
20 Another treatment option for locally advanced hepatocellular… (10.1051/vcm/2022003)
ORCID
7.53 1
21 The first reported case of a patient with small cell lung ca… (10.1051/vcm/2023003)
ORCID
7.53 1
22 Inspiring art pieces and legendary stories for cancer patien… (10.1051/vcm/2023004)
ORCID
7.53 1
23 Loss of monoacylglycerol O-acyltransferase 2 can be compensa… (10.1051/vcm/2023006)
ORCID
7.53 1
24 Recent progress in the treatment of locally advanced head an… (10.1051/vcm/2025009)
ORCID
7.53 1
25 Metastasis of nasopharyngeal carcinoma: What we know and do… (10.1051/vcm/2021003)
0.00 16
26 ACE2 in tumor cells and tumor vasculature: Negligible interc… (10.1051/vcm/2021004)
0.00 3
27 The innovation and clinical application of ischemia-free org… (10.1051/vcm/2021005)
ORCID
0.00 0
28 WTX beyond WNT signaling pathway (10.1051/vcm/2022006)
ORCID
0.00 0
29 Functions of glutaminyl cyclase and its isoform in diseases (10.1051/vcm/2022008)
0.00 20
30 Semaphorin 4C accelerates disease progression and enables di… (10.1051/vcm/2023002)
0.00 3
31 Tumor mineralization-based cancer diagnosis and therapy (10.1051/vcm/2024001)
0.00 0
32 Beam range uncertainty and its clinical management in partic… (10.1051/vcm/2024004)
0.00 2
33 The 150 most important questions in cancer research and clin… (10.1051/vcm/2024005)
ORCID
0.00 0
34 Quasi-experimental design for external control arm studies a… (10.1051/vcm/2024006)
ORCID
0.00 0
35 Enhancing real-world studies with artificial intelligence: a… (10.1051/vcm/2024009)
ORCID
0.00 0
36 Artificial intelligence plus molecular profiling for persona… (10.1051/vcm/2024011)
ORCID
0.00 0
37 Detection and characterization of circulating tumor cells an… (10.1051/vcm/2024012)
0.00 0
38 Grisotti flap for central quadrant breast tumours: quick, co… (10.1051/vcm/2025002)
0.00 1
39 Anti-cancer immunotherapy-related cardiotoxicity: preventabl… (10.1051/vcm/2025003)
0.00 1
40 Review of radiotherapy combined with systemic therapy for ad… (10.1051/vcm/2025004)
ORCID
0.00 0
41 Revisiting the role of cell death in cancer – promotion rath… (10.1051/vcm/2025006)
ORCID
0.00 0
42 Cancer therapeutics hope: microRNA clinical practice and per… (10.1051/vcm/2025007)
ORCID
0.00 0
43 The next steps for chemo-optimization in lung cancer treatme… (10.1051/vcm/2025008)
ORCID
0.00 0
44 Tumor-infiltrating lymphocyte therapy: therapeutic advances… (10.1051/vcm/2025010)
0.00 1
45 m <sup>6</sup> A mod… (10.1051/vcm/2025011)
ORCID
0.00 0
46 Advances in basic and translational research on the heteroge… (10.1051/vcm/2025012)
ORCID
0.00 0
47 Hepatic parenchymal resection with waterjet in the malignant… (10.1051/vcm/2025013)
0.00 0
48 Corrigendum to: Loss of monoacylglycerol O-acyltransferase 2… (10.1051/vcm/2025014)
Abstract References ORCID
0.00 0
49 From single-cell snapshots to spatial panoramas – a holistic… (10.1051/vcm/2025015)
0.00 0
50 Interwoven control of histone lactylation: metabolic enzymes… (10.1051/vcm/2025016)
0.00 0